Panattoni, Laura http://orcid.org/0000-0002-5081-5043
Kearney, Mairead
Land, Natalie
Flottemesch, Thomas
Sullivan, Patrick
Kirker, Melissa
Bharmal, Murtuza
Hauber, Brett
Article History
Accepted: 21 January 2024
First Online: 12 March 2024
Declarations
:
: This study was sponsored by Merck (CrossRef Funder ID: ExternalRef removed) and was previously conducted under an alliance between Merck and Pfizer.
: LP, NL, TF, and PS are employees of PRECISIONheor, a research consultancy that provides health economics and outcomes research services to life sciences companies, which received funding from the sponsor to conduct this study. MKe is an employee of Merck Healthcare KGaA, Darmstadt, Germany. MKi and BH are employees of Pfizer. MB was an employee of EMD Serono, Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA, at the time the study was conducted.
: The study protocol and materials were reviewed by an Advarra Institutional Review Board and were determined to be exempt from full review (protocol no. 00046328).
: All survey participants provided informed consent.
: The dataset for this study is available from the corresponding author on reasonable request.
: All authors made a significant contribution to this research, including the conception, study design, execution, acquisition of data, and analysis. All authors took part in drafting, revising, or critically reviewing the article and gave final approval of the version to be published.